Page last updated: 2024-09-03

umifenovir and Critical Illness

umifenovir has been researched along with Critical Illness in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Luo, S; Tian, M; Wang, L; Xia, W; Zeng, Y; Zha, Y; Zhang, K; Zhang, X1
Li, Y; Lu, X; Ruan, X; Wang, J; Wang, K; Xu, Z; Yan, F; Zhang, B1

Other Studies

2 other study(ies) available for umifenovir and Critical Illness

ArticleYear
The combined therapy of a traditional Chinese medicine formula and Western medicine for a critically ill case infected with COVID-19.
    Complementary therapies in medicine, 2020, Volume: 52

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Critical Illness; Drug Combinations; Drugs, Chinese Herbal; Female; Humans; Indoles; Lopinavir; Medicine, Chinese Traditional; Methylprednisolone; Middle Aged; Moxifloxacin; Noninvasive Ventilation; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Qi; Ritonavir; SARS-CoV-2

2020
Liver injury after antiviral treatment of critically ill patients with COVID-19: a single-centered retrospective cohort study.
    Annals of palliative medicine, 2021, Volume: 10, Issue:3

    Topics: Antiviral Agents; Chemical and Drug Induced Liver Injury; China; COVID-19 Drug Treatment; Critical Illness; Humans; Indoles; Liver; Retrospective Studies

2021